Extracellular serine protease

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S328000, C530S350000

Reexamination Certificate

active

07083790

ABSTRACT:
The present invention provides a DNA encoding a novel extracellular serine protease termed Tumor Antigen Derived Gene-14 (TADG-14) which is overexpressed in ovarian, breast and colon carcinoma samples. Also provided are vector and host cells capable of expressing the DNA of the present invention, as well as the uses of the DNA and protein of the present invention.

REFERENCES:
patent: 6080409 (2000-06-01), Laus et al.
patent: 6100059 (2000-08-01), Southan et al.
patent: 6203979 (2001-03-01), Bandman et al.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Kuby et al., 1994, Immunology, second edition, pp. 85-96.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 491-495.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Extracellular serine protease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extracellular serine protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracellular serine protease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3627438

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.